Produkty dla api farmaceutyczna (34)

98%

gemahlenes Pflanzenmaterial

with 'Mother', unfiltered, unrefined & unpasteurized

Doxazosin Mesylate is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads 77883-43-3. It is used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia - BPH. Doxazosin mesylate is a selective α-blocker that selectively binds to α1-receptors, thus dilating peripheral blood vessels. This reduces blood pressure and cholesterol levels of the serum. Detailed specification, Certificate of Analysis and samples are available on request. CAS:77883-43-3 Product Information:API Route of Synthesis:Synthetic Patent Expiry:EU, US - expired Indication:Antihypertensive, Adrenergic Blocker Dosage:Oral formulation